BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

39 hedge funds and large institutions have $10.8M invested in Bellerophon Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$508K
2
+$255K
3
+$104K
4
LCM
Laurion Capital Management
New York
+$104K
5
Citadel Advisors
Citadel Advisors
Florida
+$104K

Top Sellers

1
-$3.93M
2
-$155K
3
-$131K
4
State Street
State Street
Massachusetts
-$117K
5
Charles Schwab
Charles Schwab
California
-$91K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6K
27
$5K
28
$4K
29
$3K
30
$3K
31
$2K
32
$2K
33
$2K
34
$2K
35
$1K
36
$1K
37
$1K
38
$348
39
$14
40
–
41
–
42
–
43
–
44
–
45
–
1
2